Premium
Drug use associated tricuspid valve infective endocarditis in pregnancy
Author(s) -
Lin Dishen,
Mullan Clancy W.,
Deshmukh Uma,
Bahtiyar Mert Ozan,
Hosier Hillary,
Lipkind Heather,
AbdelRazeq Sonya,
Ranjan Saurabh,
Lancaster Gilead,
Pietras Colleen
Publication year - 2020
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.14888
Subject(s) - medicine , tricuspid valve , pregnancy , perioperative , gestation , obstetrics and gynaecology , endocarditis , infective endocarditis , intravenous antibiotics , surgery , obstetrics , antibiotics , genetics , biology , microbiology and biotechnology
Abstract Background and Aim We report a case of intravenous drug use associated tricuspid valve endocarditis in a 28‐year‐old pregnant female at 26‐week gestation. Methods Patient management required a multidisciplinary collaboration between cardiac surgery, obstetrics and gynecology, and neonatal critical care. Results Despite appropriate intravenous antibiotics, the patient developed life‐threatening complications and underwent planned cesarean delivery at 28 weeks 6 days gestation followed by interval tricuspid valve replacement 1 week later. Conclusions Both the patient and her infant were successfully managed through the perioperative period.